Expression and motogenic activity of TFF2 in human breast cancer cells

Peptides

Volumn 25, Issue 5, 2004, Pages 865-872

  May, Felicity E B ^a   Semple, Jennifer I ^a   Prest, Sara J ^a   Westley, Bruce R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Breast cancer cells; Breast tumor; Estrogen; Estrogen receptor; Human breast cancer; Metastasis; Motility; pS2; TFF1; TFF2; TFF3; Trefoil peptide; Trefoil protein

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST TUMOR; CANCER CELL; CANCER CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BREAST NEOPLASMS; CELL MOVEMENT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MUCINS; MUSCLE PROTEINS; PEPTIDES; RECEPTORS, ESTROGEN; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

LOTUS; MINK CELL FOCUS-FORMING VIRUS;

EID: 2642517796     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.12.024     Document Type: Article

References (46)

1. Beatson G.T. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet. II:1896;104-107
2. Berry M., Nunez A.M., Chambon P. Estrogen-responsive element of the human pS2 gene in an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. U.S.A. 86:1989;1218-1222
3. Carr M., May F.E.B., Lennard T.W.J., Westley B.R. Determination of oestrogen responsiveness of breast cancer by competitive reverse transcription-polymerase chain reaction. Br. J. Cancer. 72:1995;1427-1434
4. Chadwick M.P., Westley B.R., May F.E.B. Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58. Biochem. J. 327:1997;117-123
5. Crosier M., Scott D., Wilson R.G., Griffiths C.D., May F.E.B., Westley B.R. High expression of the trefoil protein TFF1 in interval breast cancers. Am. J. Pathol. 159:2001;215-221
6. Donaghue C., Westley B.R., May F.E.B. Selective promoter use of the estrogen receptor-α gene and its regulation by estrogen. Mol. Endocrinol. 13:1999;1934-1950
7. Foekens J.A., Potengan H., Look M.P., van Putten W.L.J., Thirion B., Bontenbal M., et al. Relationship of pS2 with response to tamoxifen therapy in patients with recurrent breast cancer. Br. J. Cancer. 70:1994;1217-1223
8. Gajhede M., Petersen T.N., Henrickson A., Petersen J.F.W., Dauter Z., Wison K.S., et al. Pancreatic spasmolytic polypeptide: first three dimensional structure of a member of the mammalian trefoil family of peptides. Structure. 1:1993;252-262
9. Gruvberger S., Ringner M., Chen Y., Panavally S., Saal L.H., Borg A., et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61:2001;5979-5984
10. Hauser F., Poulsom R., Chinery R., Rogers L.A., Hanby A.M., Wright N.A., et al. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6961-6965
11. Henry J.A., Nicholson S., Hennessy C., Lennard T.W.J., May F.E.B., Westley B.R. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Br. J. Cancer. 61:1989;32-38
12. Henry J.A., Piggott N.H., Mallick U.K., Nicholson S., Farndon J.R., Westley B.R., et al. pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br. J. Cancer. 63:1991;615-622
13. Hoffman W., Jagla W. Cell type specific expression of secretory TFF peptides: colocalization with mucins and synthesis in the brain. Int. Rev. Cytol. 213:2002;147-181
14. Jakowlew S.B., Breathnach R., Jeltsch J.M., Masiakowski P., Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res. 12:1984;2861-2878
15. Johnson M.D., Westley B.R., May F.E.B. Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells. Br. J. Cancer. 59:1989;727-738
16. Lalani E.N., Williams R., Jayaram Y., Gilbert C., Chaudhary K.S., Siu L.S., et al. Trefoil factor-2, human spasmolytic polypeptide, promotes branching morphogenesis in MCF-7 cells. Lab. Invest. 79:1999;537-546
17. Lefebvre O., Chenard M.P., Masson R., Linares J., Dierich A., LeMeur M., et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science. 274:1996;259-262
18. Lemercinier X., Muskett F.W., Cheeseman B., McIntosh P.B., Thim L., Carr M.D. High-resolution structure of human intestinal trefoil factor and functional insights from detailed structural comparisons with other members of the trefoil family of mammalian motility factors. Biochemistry. 40:2001;9552-9559
19. Masiakowski P., Breathnach R., Bloch J., Gannon F., Krust A., Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10:1982;7895-7903
20. May F.E.B., Semple J.I., Newton J.L., Westley B.R. The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach. Gut. 46:2000;454-459
21. May F.E.B., Westley B.R. Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells. Cancer Res. 46:1986;6034-6040
22. May F.E.B., Westley B.R. Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen-regulated RNAs in human breast cancer cells. J. Biol. Chem. 262:1987;15894-15899
23. May F.E.B., Westley B.R. Identification and characterization of estrogen-regulated RNAs in human breast cancer cells. J. Biol. Chem. 263:1988;12901-12908
24. May F.E.B., Westley B.R. Trefoil proteins their role in normal and malignant cells. J. Pathol. 182:1997;404-413
25. May F.E.B., Westley B.R. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J. Pathol. 183:1997;4-7
26. Otto W.R., Rao J., Cox H.M., Kotzian E., Lee C.Y., Goodlad R.A., et al. Effects of pancreatic spasmolytic polypeptide (PSP) on epithelial cell function. Eur. J. Biochem. 235:1996;64-72
27. Perou C.M., Sorlie T., Elsen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., et al. Molecular portraits of human breast tumors. Nature. 406:2000;747-752
28. Piggott N.H., Henry J.A., May F.E.B., Westley B.R. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J. Pathol. 63:1991;95-104
29. Polshakov V.I., Williams M.A., Gargaro A.R., Frenkiel T.A., Westley B.R., Chadwick M.P., et al. High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein. J. Mol. Biol. 267:1997;418-432
30. Poulsom R., Hanby A.M., Lalani E.N., Hauser F., Hoffman W., Stamp G.W.H. Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic breast epithelium. J. Pathol. 183:1997;30-38
31. Poulsom R., Wright N.A. Trefoil peptides: a newly recognized family of mucin-associated molecules. Am. J. Physiol. 265:1993;205-213
32. Prest S.J., May F.E.B., Westley B.R. The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J. 16:2002;592-594
33. Prud'homme J.F., Fridlansky F., Le Cunff M., Atger M., Mercier-Bodart C., Pichon M.F., et al. Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA. 4:1995;11-21
34. Rio M.C., Bellocq J.P., Gairard B., Rasmussen B., Krust A., Koehl C., et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the oestrogen and progesterone receptors and the oncogene ErbB2. Proc. Natl. Acad. Sci. U.S.A. 84:1987;9243-9247
35. Schmitt A.O., Specht T., Beckmann G., Dahl E., Pilarsky C.P., Hinzmann B., et al. Exhaustive mining of EST libraries for genes differentially expressed in normal and tumor tissues. Nucleic Acids Res. 27:1999;4251-4260
36. Schwartz L.H., Koerner F.C., Edgerton S.M., Sawicka J.M., Rio M.C., Bellocq J.P., et al. pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Cancer Res. 51:1991;624-628
37. Soubeyran I., Quenel N., Coindre J.M., Bonichon F., Durand M., Wafflart J., et al. pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients. Br. J. Cancer. 74:1996;1120-1125
38. Suemori S., Lynch-Devaney K., Podolsky D.K. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc. Natl. Acad. Sci. U.S.A. 88:1991;11017-11021
39. Tomasetto C., Rio M.C., Gautier C., Wolf C., Hareuveni M., Chambon P., et al. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J. 9:1990;407-414
40. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536
41. Wiede A., Jagla W., Welte T., Köhnlein T., Busk H., Hoffman W. Localization of TFF3, a new mucus-associated peptide of the human respiratory tract. Am. J. Respir. Crit. Care Med. 159:1999;1330-1335
42. West M., Blanchette C., Dressman C., Huang E., Ishida S., Spang R., et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. U.S.A. 98:2001;11462-11467
43. Westley B., May F.E.B., Brown A.M.C., Krust A., Chambon P., Lipmann M.E., et al. Effects of anti-estrogens on the estrogen regulated pS2 RNA, 46K and 160K proteins in MCF-7 cells and two tamoxifen resistant sublines. J. Biol. Chem. 259:1984;10030-10036
44. Williams M.A., Westley B.R., May F.E.B., Feeney J. The solution structure of the disulphide-linked homodimer of the human trefoil protein TFF1. FEBS Lett. 493:2001;70-74
45. Wilson Y.G., Rhodes M., Ibrahim N.B.M. Immunocytochemical staining of pS2 protein in fine-needle aspirates from breast cancer is an accurate guide to response to tamoxifen in patients aged over 70 years. Br. J. Surg. 81:1994;1155-1158
46. Wiseman L.R., Wakeling A.E., May F.E.B., Westley B.R. Effects of the antioestrogen, ICI 164, 384, on oestrogen induced RNAs in MCF-7 cells. J. Steroid Biochem. 33:1989;1-6